Ryan Gonciarz

Ryan Gonciarz is a highly skilled Senior Scientist I in Medicinal Chemistry at Exelixis, focusing on the design and synthesis of small molecules for difficult-to-treat cancers since January 2023. Prior experience includes a postdoctoral role at Merck, where methodology for stereocontrolled synthesis of 1,2,4-trioxolanes was developed for pancreatic cancer research. Additionally, Ryan worked as a postdoctoral researcher at the University of California, San Francisco, and completed a PhD at the University of Leeds, specializing in antibacterial agents for multidrug-resistant Gram-negative pathogens. Earlier in their career, Ryan gained practical experience at Enviroco Limited and Veolia, where process-scale fuel synthesis was performed under industry standards. Ryan also holds a Master's degree in Chemical Biology and Drug Design and a Bachelor's degree in Pharmaceutical Science.